10 studies found for:    Pulmonary Sarcoidosis AND NIH Clinical Center in Bethesda, Md
Show Display Options
Rank Status Study
1 Recruiting Atorvastatin to Treat Pulmonary Sarcoidosis
Condition: Sarcoidosis, Pulmonary
Intervention: Drug: Atorvastatin
2 Completed Eye and Immunogenetic Features of Sarcoidosis
Conditions: Sarcoidosis;   Uveitis
Intervention:
3 Recruiting Role of Genetic Factors in the Development of Lung Disease
Conditions: Cystic Fibrosis;   Sarcoidosis;   Tuberous Sclerosis;   Asthma
Intervention:
4 Recruiting Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Conditions: Pulmonary Disease;   Oropharyngeal Disease;   Lymphangioleiomyomatosis;   Pulmonary Fibrosis;   Asthma;   Sarcoidosis
Intervention:
5 Completed Immunotoxin Therapy in Treating Patients With Advanced Cancer
Conditions: Cervical Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Ovarian Cancer;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Biological: SS1(dsFv)-PE38 immunotoxin
6 Completed Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Conditions: Cervical Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Ovarian Cancer;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Biological: SS1(dsFv)-PE38 immunotoxin
7 Recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Drug: SS1P
8 Completed A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Conditions: Non-Small Cell Lung Cancer;   Adenocarcinoma
Interventions: Drug: SS1 (dsFv) PE38;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab
9 Completed Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
Conditions: Asthma;   Hypersensitivity;   Lung Diseases;   Wegener's Granulomatosis
Intervention:
10 Active, not recruiting SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: SS1P;   Drug: Pemetrexed;   Drug: Cisplatin

Indicates status has not been verified in more than two years